… with tumor-exosome (TEX)-loaded dendritic cells (DC) can be improved by combining with
drugs affecting myeloid-derived suppressor cells (MDSC). Experiments were performed with …

… The immunological outcome of dendritic cell (DC) treatment … Treatment of DCs with PLGA
or chitosan films supported DC … Dendritic cells treated with HA film expressed lower levels of …

… Dendritic cells (DCs) play a key role in initiating immune responses and maintaining immune
… VDR is expressed on immune cells such as DCs and Vitamin D treatment of DC inhibits …

… treatment with DCs and cytokine-induced killer cells (CIK) combined with bortezomib and
dexamethasone improved CD4 + /CD8 + T-cell ratios compared to baseline and treatment with …

… to be subject to T cell-mediated immunity ( 1 ) and, therefore, is a candidate for vaccination
approaches. Dendritic cells (DC) are very potent immunostimulatory cells and due to this …

… cells. Dendritic cells DCs could play a pivotal role in enhancing the antitumor efficacy of CIKs.
… It was also found that CIK cells treatment had comparable adverse events compared to the …

… We demonstrate that treatment of immature DC with IL- 10 inhibits the expression of MHC
class 11, the costimulatory molecules CD58 and CD86, and the DC marker Ag CD83. More …

… Another approach is through vaccination; that is, the provision of an antigen together with
an adjuvant to elicit therapeutic T cells in vivo. Owing to their properties, dendritic cells (DCs) …

… cells (LC), myeloid-derived dermal dendritic cells (mDC) and plasmacytoid dendritic cells
(… This may be relevant for the treatment of squamous cell carcinoma, where we have shown …

… and treatment responsiveness. Although dendritic cells (DCs) constitute a rare immune
cell population within tumours and lymphoid organs, these cells are central for the initiation of …